Cargando…
SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer
Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in incidence worldwide, opening the discussion about the need for screening. However, no established screening tool currently exists for RC. To tackle this issue, we assessed surface-enhanced Raman scattering (SERS) profiling...
Autores principales: | Moisoiu, Tudor, Iancu, Stefania D., Burghelea, Dan, Dragomir, Mihnea P., Iacob, Gheorghita, Stefancu, Andrei, Cozan, Ramona G., Antal, Oana, Bálint, Zoltán, Muntean, Valentin, Badea, Radu I., Licarete, Emilia, Leopold, Nicolae, Elec, Florin I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869590/ https://www.ncbi.nlm.nih.gov/pubmed/35203443 http://dx.doi.org/10.3390/biomedicines10020233 |
Ejemplares similares
-
Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer
por: Moisoiu, Tudor, et al.
Publicado: (2022) -
Successful partial nephrectomy of a T1b multilocular clear cell renal cell carcinoma arising in a renal graft
por: Elec, Florin Ioan, et al.
Publicado: (2018) -
Renal Tumors in Young Adults: Is Preoperative Computer Tomography Imaging Suggestive for the Nature of the Tumors?
por: Zaharie, Andreea, et al.
Publicado: (2020) -
The role of Ag(+), Ca(2+), Pb(2+) and Al(3+) adions in the SERS turn-on effect of anionic analytes
por: Iancu, Stefania D, et al.
Publicado: (2019) -
The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report
por: Antal, Oana, et al.
Publicado: (2023)